Health
Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes – News-Medical.Net
Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way.
Reviewed by Emily Henderson, B.Sc.Nov 16 2020
Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way.
Since that time, evidence in favor of the use of sodium/glucose cotransporter 2 (SGLT2) inhibitors has been mounting, with studies showing better blood glucose control, cardiovascular benefits, weight loss and more for patients with diabetes taking SGLT2 inhibitors.
Now, two large clinical trials, conducted by investigators at…
-
General24 hours agoCanberra man named as doctor accused of rape after suppression order lifted
-
Noosa News23 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General22 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
Noosa News23 hours agoMelbourne Market vendors say new rent offer too expensive as eviction threat looms